The information and content contained on this webpage is intended to be used or viewed solely in jurisdictions where it is lawful to do so. If you access the broker research reports contained herein (Analyst Reports), you must inform yourself about, and comply with, applicable laws and regulations, including (without limitation) observing securities laws and regulations in jurisdictions that impose restrictions on the distribution of such Analyst Reports.
Rhythm Biosciences Limited, its directors, officers, employees, associates, affiliates and agents disclaim all liability and responsibility for any direct or indirect loss, or damage, which may be incurred by any recipient through any information, omission, error, or inaccuracy contained in the Analyst Reports.
All information, opinions, conclusions, estimates or recommendations provided in the Analyst Reports have been prepared by third parties and Rhythm Biosciences Limited, its directors, officers, employees, associates, affiliates and agents make no representation or warranty as to the accuracy, completeness, or reliability of information prepared by third parties, including any price target, earnings forecast or other statements (including forward- looking statements) about Rhythm Biosciences Limited’s business activities.
By proceeding, you agree that you are a sophisticated investor or that you will seek professional financial advice before buying or selling any securities referred in the Analyst Reports contained herein.
By proceeding to access the Analyst Reports you are confirming and agreeing that your access does not violate applicable laws, including the laws of your home jurisdiction and you have read, understood and accept the disclaimer as outlined above.
29 November 2022 - MST Access "Update"
5 July 2022 - MST Access "Approval to Unblock an Expanded Market"
12 April 2022 - Pitt Street Reserach "Update - Study 7 is Another Success"
21 April 2022 - MST Access " Update - Study 7 Opens Market Opportunities"
7 Decemebr 2021 - Pitt Street Research "Ticket booked to Europe"
12 November 2021 - MST Access " Market Entries in Sight"
17 June 2021 - MST Access "Breakthrough Bowel Cancer Diagnostic"
18 May 2021 - Pitt Street Research " Bowel Cancer Screening Made Simple"
Copyright | Rhythm Biosciences - ABN 59 619 459 335
Bio21 Institute 30 Flemington Road Parkville VIC 3010 Australia